Navigation Links
Study shows no increased risk of breast cancer for non-carriers in families with BRCA gene mutation
Date:10/31/2011

In this News Digest:

  • Summary of a study being published online Oct. 31, 2011, in the Journal of Clinical Oncology finding that close relatives of women who carry mutations in a BRCA gene - but who themselves do not have such genetic mutations -- do not have an increased risk of developing breast cancer compared to relatives of women with breast cancer who do not have such mutations. These results run counter to a previous study showing a higher risk for these women, and suggest they may not need extra cancer screening and other preventive measures.
  • Quote for attribution to Andrew Seidman, MD, American Society of Clinical Oncology Cancer Communications Committee member and breast cancer specialist.
  • Links to additional information on http://www.Cancer.Net, ASCO's patient Website

A population-based analysis of more than 3,000 families including women with breast cancer has found that close relatives of women who carry mutations in a BRCA gene - but who themselves do not have such genetic mutations - do not have an increased risk of developing breast cancer compared to relatives of women with breast cancer who do not have such mutations. While these results support most previous evidence regarding risks for non-carriers of BRCA mutations, they run counter to a 2007 study that indicated first-degree relatives (mothers, sisters and daughters) of women with BRCA gene mutations are several times more likely than the general population to develop breast cancer - despite not having the mutation themselves. The new findings suggest that women who test negative for the mutation may not need extra cancer screening and other increased preventive measures.

"This new study gives reassurance to non-carriers that they do not have an increased risk due to the familial mutation, and should be regarded the same as other non-carriers with first-degree relatives who have had breast cancer
'/>"/>

Contact: Nicole Fernandes
nicole.fernandes@asco.org
571-483-1354
American Society of Clinical Oncology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. The freshman 15 is just a myth, nationwide study reveals
2. First-of-its-kind study creates new tool for targeted cancer drug development
3. Study finds community counseling reduced the prevalence of TB on a budget
4. Practice Doesnt Always Make Perfect, Study Suggests
5. NYUCN receives $4.2 million NIH/NIDA grant to study injecting drug users in Kenya
6. NYUCN receives $2.8 million NIH/NIAID grant to study combination HIV prevention for Kenyan youth
7. Study finds no link between elderly patient activity and hospital falls
8. UT study looks at manual wheelchair use, exercise and calorie burning
9. Study finds specific gene linked to cold sore susceptibility
10. Poorer Countries Have Higher Rates of Stroke, Study Finds
11. NYUCN receives $299 thousand from NCSBN to study patient safety in nursing homes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Restricting access to firearms for people ... that more clearly define alcohol misuse should be developed ... research and public policies by the UC Davis Violence ... 30 in the peer-reviewed journal Preventive Medicine , ... alcohol misuse in association with firearm access and use, ...
(Date:5/28/2015)... Scotch Plains, NJ (PRWEB) May 28, 2015 ... Dr. Farhad Rafizadeh, specializes in delivering world-class results. ... of Plastic Surgery and a background in art, Dr. ... look. His unique approach to Plastic Surgery involves ... addition, his practice delivers a superior level of comfort ...
(Date:5/28/2015)... May 28, 2015 Medelis, Inc., a ... joined the company in the role of president. , “ ... in the CRO industry,” said Larry Flanagan, Medelis’ CEO and ... company through our next phase of growth.” , Taaffe ... growth from nine employees to over 4,500 employees, achieving 12 ...
(Date:5/28/2015)... Boston Celtics Legend and Basketball Hall of ... Board of Directors members, will be hosting their 34th ... 4-7. For the past 34 years, the Havlicek’s have ... for children by bringing together friends, families, and celebrities ... Havlicek Celebrity Fishing Tournament will be held from June ...
(Date:5/28/2015)... May 28, 2015 Workers’ compensation costs per ... state, a recent study by the Workers Compensation Research ... a three-year period. , The WCRI study, CompScope™ Benchmarks ... workers missed seven days or more of work with those ... average 2011 Michigan claim was 4 percent lower than similar ...
Breaking Medicine News(10 mins):Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 2Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 4Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 2Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 3Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2Health News:The Genesis Foundation Prepares for Their Final Annual John Havlicek Celebrity Fishing Tournament 2Health News:Michigan Workers’ Compensation Costs Lower Than Most States, Says WCRI Study 2
... that subconjunctivally delivered insulin ameliorates degenerative and inflammatory responses ... Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting ... on Thursday, May 10 from 10:45 a.m. to 12:30 ... County Convention Center. ,Regular human insulin in ...
... to uncover the medium- and large-scale genetic differences between humans ... wide range of diseases, according to a paper by Howard ... in the May 10, 2007, Nature. The undertaking will help ... amount to as much as five to ten percent of ...
... systems of humans and opossums, the famous Australian marsupial ... in the understanding and treatment of facial tumours afflicting ... the Australian island state of Tasmania. ... genetic information of the South American opossum, the first ...
... two-thirds of US children undergo some trauma or ... them experience post-traumatic stress disorder. ,The ... it also suggests that the way children process troubling ... Duke University Medical Center, whose study appeared in the ...
... at St. Jude Children's Research Hospital had a molecules ... as it assembled on a double-strand break to ... that cut completely across the twisted, ladder-like structure of ... a technique developed specifically for this project, the St. ...
... People infected with the hepatitis C virus (HCV) are ... of the lymphatic system), according to a study ... Journal of the American Medical Association. Researchers from the ... of Health, and Baylor College of Medicine, found that ...
Cached Medicine News:Health News:Cataloging the Structural Variations in Human Genetics 2Health News:Cataloging the Structural Variations in Human Genetics 3Health News:Treatment of Premature Babies, Opossums Could Help 2Health News:Two-thirds of US Children Experience Trauma, but Recover Fast 2Health News:DNA Repair Proteins Monitored at Double-strand Break 2Health News:Risk of Lymphoma Increases With Hepatitis C Virus Infection 2
(Date:5/28/2015)... and CAMBRIDGE, Mass., May 28, 2015  Shareholder rights ... whether certain officers and directors of Eleven ... shareholders.  Eleven Biotherapeutics is a clinical-stage biopharmaceutical company ... protein therapeutics to treat eye diseases, primarily in ... View this press release on the ...
(Date:5/28/2015)... , May 27, 2015 The amount Americans ... in 2014 and with growth of 8% will reach ... out of pocket: directly on expenditures, co-pays as part ... and on premiums.  The publisher made its finding in ... the United States . ...
(Date:5/28/2015)... , May 28, 2015 ... Testing Market - Size, Industry Analysis, Trends, Opportunities, Growth and ... reach $3.6 billion by 2020. The secondary syphilis testing ... 2020. Latin America , ... (LAMEA) market accounted for about 43% revenue share ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 3Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3
... Global Sources (Nasdaq: GSOL ) has ... China Sourcing Fairs at Hong ... the renewed contracts announced in June 2010, representing a ... (Logo: http://photos.prnewswire.com/prnh/20030303/LNM011LOGO-b) Under the terms of the ...
... (Nasdaq: AMGN ) today announced the publication ... 1,776 advanced cancer patients with different types of solid ... myeloma, which compared XGEVA ™ (denosumab) to Zometa® ... which appeared today in the Journal of Clinical ...
Cached Medicine Technology:Global Sources extends its contract with AsiaWorld-Expo to host China Sourcing Fairs in Hong Kong through 2014 2Global Sources extends its contract with AsiaWorld-Expo to host China Sourcing Fairs in Hong Kong through 2014 3The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 2The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 3The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 4The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 5The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 6The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 7The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 8
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: